Translational Drug Development (TD2) in Scottsdale, AZ is a leading oncology Contract Research Organization (CRO) specializing in precision oncology. Since 2003, TD2 has been dedicated to accelerating cancer drug development by offering comprehensive services from preclinical research to clinical trial management.
Their expert team collaborates with biotech and pharma companies to translate scientific hypotheses into patient responses, guiding therapies through regulatory processes and clinical trials with innovative and data-driven approaches. With a focus solely on oncology, TD2 is committed to advancing cancer therapies from early detection to market approval.
Generated from the website